Table 3 A multivariate analysis of a likelihood of a positive test for COVID-19

ACEIs or ARBs

1.01 (0.89–1.13)

0.9345

61–69

1.36 (1.2–1.53)

<.0001

70–79

1.03 (0.91–1.18)

0.3633

≥80

0.7 (0.6–0.8)

<.0001

Female

1.33 (1.21–1.46)

<.0001

Diabetes mellitus

0.92 (0.84–1.01)

0.0739

Cardiovascular disease

0.89 (0.73–1.09)

0.2599

Cerebrovascular disease

0.76 (0.67–0.87)

<.0001

Ischemic heart disease

0.65 (0.55–0.75)

<.0001

COPD

0.43 (0.32–0.58)

<.0001

Malignancy

0.31 (0.26–0.37)

<.0001

Renal replacement therapy

0.19 (0.13–0.29)

<.0001